StockTipsArenaBeta

BUY Concord Biotech Limited — IDBI Capital

BUYConcord Biotech Limited
Concord Biotech share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred 1–3 months)13 Jul 2026via IDBI Capital Research Calls Telegram

Entry₹1,330Stated
Target₹1,450
Total upside +9.02% (call closed)
Stop loss₹1,270-4.51% risk
Exit₹1,27023 Jul 2026, 12:07 pm
Stop-loss hit-4.51%
Follow IDBI Capital for new calls(32% target hit, 185 closed calls)Get alertsWatch CONCORDBIO for new buy/sell callsGet alertsSee 32 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 23 Jul 2026
2 supporting0 opposing
Supports the BUY call (2)

Nothing found in this tip’s window yet.

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Concord Biotech

All analyst calls on Concord Biotech

More from IDBI Capital

Every call and its outcome